Flamingo Pharmaceuticals Limited, a active public limited company, was established on 12 June 1985 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51900MH1985PLC036572. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹6.80 Cr.
Formerly known as Flamingo Impex Limited, Flamingo Impex P Limited. It upholds a compliant status. Employing 552 professional, Its leadership includes Parth Ashwin Thacker (Director), Chhotulal Rawa Bhagwat (Director), Pranay Ashwin Thacker (Director). Past directors included Archana Shashikant Padwal, Sandip Keshav Pawar, Uday Anant Sawant. It holds ₹121.37 Cr open charges and ₹452.45 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 7/1, Corporate Park, Sion-Trombay Road, P.O.Box No. : 27257,, Chembur,, Mumbai, Maharashtra, 400071.
U51900MH1985PLC036572
036572
12 June 1985
₹10.00 Cr
₹6.80 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Flamingo Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parth Ashwin Thacker | Director | 10 Nov 2023 | Current |
| Chhotulal Rawa Bhagwat | Director | 25 Oct 2022 | Current |
| Pranay Ashwin Thacker | Director | 08 Jun 2021 | Current |
| Ashwin Jethalal Thacker | Director | 23 Jun 1986 | Current |
| Meena Sanjiv Kapadi | Director | 28 Sep 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | 23 Sep 2021 | Past |
| Pramod Abcsdd | Director | 28 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Company Secretary | 03 May 2018 | Past |
| Pramod Abcsdd | Director | 27 Feb 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Flamingo Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.44% increase. The company also saw a slight improvement in profitability, with a 5.61% increase in profit. The company's net worth moved up by a moderate rise of 9.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Flamingo Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,213,700,000.00
₹4,524,542,097.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2023 | Others | ₹2.20 M | Open |
| 18 Nov 2022 | Others | ₹18.15 Cr | Open |
| 22 Feb 2022 | Others | ₹20.00 Cr | Open |
| 09 Oct 2015 | Others | ₹13.00 Cr | Open |
| 29 Sep 2015 | Others | ₹5.00 Cr | Open |
Explore comprehensive loan charge details -
Flamingo Pharmaceuticals has a workforce of 552 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Flamingo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Flamingo Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Flamingo Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.
Progress on Ashish Tayal was appointed as a Cfo was appointed as a Cfo on 24 Apr 2025 & has been associated with this company since 7 months 10 days . was documented.
Progress on Flamingo Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Progress on A charge registered on 24 Jan 2024 via Charge ID 100923017 with Yes Bank Limited was fully satisfied on 17 Oct 2024. was documented.
The activity A charge with Others of Rs. 43.00 Cr registered on 18 Jun 2014 with Charge ID 10504887 was modified on 20 Jul 2024. was completed.
A charge with Yes Bank Limited amounted to Rs. 20.00 Cr with Charge ID 100923017 was registered on 24 Jan 2024. was recorded as a recent event.
The CIN of Flamingo Pharmaceuticals Limited is U51900MH1985PLC036572.
Flamingo Pharmaceuticals Limited is headquartered at 7/1, Corporate Park, Sion-Trombay Road, P.O.Box No. : 27257,, Chembur,, Mumbai, Maharashtra, 400071.
Flamingo Pharmaceuticals Limited was incorporated on 12 June 1985.
The current directors of Flamingo Pharmaceuticals Limited are
The primary industry of Flamingo Pharmaceuticals Limited is Manufacturing.
Flamingo Pharmaceuticals Limited is unlisted.
The authorized capital of Flamingo Pharmaceuticals Limited is ₹10.00 Cr, and the paid-up capital is ₹6.80 Cr.
The compliance status of Flamingo Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX